Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CD80 Protein (CD80)

Cette protéine Recombinant CD80 est produite dans HEK-293 Cells.
N° du produit ABIN7849732
1.155,00 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 9 à 11 jours ouvrables

Aperçu rapide pour CD80 Protein (CD80) (ABIN7849732)

Antigène

Voir toutes CD80 Protéines
CD80

Type de proteíne

Recombinant

Origine

  • 25
  • 24
  • 7
  • 6
  • 3
  • 3
Humain

Source

  • 26
  • 8
  • 8
  • 5
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
HEK-293 Cells

Application

SDS-PAGE (SDS)

Pureté

>85 % by SDS-PAGE
  • Fonction

    Recombinant Human CD80 Protein

    niveau d'endotoxine

    <1.0EU per μg of the protein as determined by the LAL method
  • Vous souhaitez d'autres options pour ce Protein ?

    !
    Découvrez nos protéines personnalisées prédéfinies et nos services de protéines sur mesure !

    Votre projet nécessite-t-il une personnalisation supplémentaire ? Contactez-nous et découvrez nos solutions protéiques sur mesure

  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Buffer

    Lyophilized from sterile PBS, pH 7.4.

    Stock

    4 °C,-20 °C,-80 °C

    Stockage commentaire

    Ship at 4°C. Upon receipt, aliquot and store at -20°C or -80°C for long term. Avoid repeated freeze and thaw cycles.
  • Antigène

    CD80

    Autre désignation

    CD80

    Sujet

    Synonyms: B7, B7-1, B7.1, BB1, CD28LG, CD28LG1, LAB7

    Description: Recombinant human CD80 protein at the C-terminus.

    Background: The B-lymphocyte activation antigen B7-1 (referred to as B7), also known as CD80, is a member of cell surface immunoglobulin superfamily and is expressed on the surface of antigen-presenting cells including activated B cells, macrophages and dendritic cells. As costimulatory ligands, B7-1 which exists predominantly as dimer and the related protein B7-2, interact with the costimulatory receptors CD28 and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) expressed on T cells, and thus constitute one of the dominant pathways that regulate T cell activation and tolerance, cytokine production, and the generation of CTL. The B7/CD28/CTLA4 pathway has the ability to both positively and negatively regulate immune responses. CD80 is thus regarded as promising therapeutic targets for autoimmune diseases and various carcinomas.

    Pathways

    TCR Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Vous êtes ici:
Chat with us!